Indicated for the treatment of critical limb ischemia (CLI), the product is the first allogeneic cell therapy to be approved for commercial use in India and the first stem cell product to be approved globally for CLI treatment. The company has partnered with Mumbai based pharma company Cipla for the marketing and distribution of the product. BioSpectrum interacted with B N Manohar, Managing Director & Chief Executive Officer, Stempeutics Research, Bengaluru to find out more about this innovative product.
What are the key highlights of Stempeucel?
The key feature of Stempeucel is that it is an on-demand, cryo-preserved, allogeneic regenerative medicine targeting unmet needs. It is physician prescribed and the drug is administered through intramuscular injections around the calf muscle region and around the site of ulcers for CLI treatment. There is a unique patented stem cell pooling technology involved. We have 57 filed patents for this product, 18 international patents granted for Stempeucel pooling technology, including United States, France, UK, Germany, Italy, China, Japan, Australia, New Zealand, Singapore, South Africa and Philippines. It is the first stem cell product with pooling technology to be classified as an Advanced Therapy Medicinal Product (ATMP) and granted Orphan Drug Designation by the European Medicines Agency (EMA) in 2015. Few other indications where this product is being explored includes an ongoing Phase 3 clinical trial for osteoarthritis and diabetic foot ulcer, ongoing Phase 1/2 study for perianal fistula due to Chron’s Disease indication; and we are starting Phase 2 COVID-19 acute respiratory distress syndrome (ARDS) study with the government support.
Please share more details about the CLI treatment procedure.
Denne historien er fra November 2020-utgaven av Bio Spectrum.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent ? Logg på
Denne historien er fra November 2020-utgaven av Bio Spectrum.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent? Logg på
Early Diabetic Retinopathy Detection Remains a Challenge
The Vitreo Retinal Society of India (VRSI) and the Research Society for the Study of Diabetes in India (RSSDI) have formulated a first-of-its kind diabetic retinopathy (DR) screening guideline to help physicians and diabetologists in India educate their patients about DR.
Promega unveils GloMax Galaxy Bioluminescence Imager for illuminating protein dynamics in real time
US-based Promega Corporation, a life-sciences research partner dedicated to providing intuitive tools that empower scientists to innovate, has unveiled the new GloMax Galaxy Bioluminescence Imager.
Qiagen launches QIAcuityDx digital PCR system for clinical testing in oncology
Qiagen N.V. has announced the launch of the QIAcuityDx Digital PCR System, a pivotal addition to its digital PCR portfolio now expanding into clinical diagnostics.
Thermo Fisher introduces iCAP MX Series ICP-MS to simplify trace elemental analysis
Thermo Fisher Scientific Inc. has launched the Thermo Scientific iCAP MX Series ICP-MS to simplify trace element analysis with inductively coupled plasma mass spectrometry (ICP-MS).
Singleron, Bioscreen to enhance access to single cell multi-omics solutions for Indian researchers
Singleron Biotechnologies, a leading innovator in single cell multi-omics solutions, has announced a strategic partnership with Bioscreen, a renowned distributor of advanced life science products in India.
IIT Madras identifies enhanced drug delivery method for eye treatments
Researchers at the Indian Institute of Technology Madras (IIT-M) have demonstrated how drugs injected in the human eye can be better delivered to the target region through ‘convection caused by mild laser heating’.
IIT Madras develops indigenous POCUS scanner for sports injury diagnosis
A team of researchers at the Indian Institute of Technology Madras (IIT-M) has developed an indigenous portable Point-of-Care-Ultrasound (POCUS) Scanner for sports injury diagnosis and management.
Practo strengthens Board with appointment of TVG Krishnamurthy and Dr Alexander Kuruvilla
Practo has appointed two new directors to its board: TVG Krishnamurthy and Dr Alexander Kuruvilla.
Dr R N Gupta steps in as National President of Indian Pharmaceutical Association
Dr R N Gupta has been elected as the National President of the Indian Pharmaceutical Association (IPA), the oldest and largest association of pharmaceutical professionals in the country, for the term 2024 - 2026 (October 1, 2024 - September 30, 2026).
QR678 brings medtech leader Sridhar Ranganathan to advisory board
QR678, a pioneering company dedicated to revolutionising hair and skin science through groundbreaking research and innovative solutions, has announced the appointment of Sridhar Ranganathan to its Board of Advisors.
